Abramson, A. (2021). Substance use during the pandemic. American Psychological Association. https://www.apa.org/monitor/2021/03/substance-use-pandemic
Alegría, M., Frank, R. G., Hansen, H. B., Sharfstein, J. M., Shim, R. S., & Tierney, M. (2021). Transforming mental health and addiction services. Health Affairs, 40(2), 226–234. https://doi.org/10.1377/hlthaff.2020.01472
Alexander, A. C., & Ward, K. D. (2018). Understanding postdisaster substance use and psychological distress using concepts from the self-medication hypothesis and social cognitive theory. Journal of Psychoactive Drugs, 50(2), 177–186. https://doi.org/10.1080/02791072.2017.1397304
Ali, M. M., Dean, D., Jr., Lipari, R., Dowd, W. N., Aldridge, A. P., & Novak, S. P. (2015). The mental health consequences of nonmedical prescription drug use among adolescents. The Journal of Mental Health Policy and Economics, 18(1), 3–15.
Ali, M. M., Dowd, W. N., Classen, T., Mutter, R., & Novak, S. P. (2017). Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health. Addictive Behaviors, 69, 65–77. https://doi.org/10.1016/j.addbeh.2017.01.011
Becker, W. C., & Starrels, J. L. (2022). Non-medical prescription drug use: Epidemiology, prevention, identification, and management. UpToDate. https://www.uptodate.com/contents/prescription-drug-misuse-epidemiology-prevention-identification-and-management
Benotsch, E. G., Zimmerman, R., Cathers, L., McNulty, S., Pierce, J., Heck, T., Perrin, P. B., & Snipes, D. (2013). Non-medical use of prescription drugs, polysubstance use, and mental health in transgender adults. Drug and Alcohol Dependence, 132(1–2), 391–394. https://doi.org/10.1016/j.drugalcdep.2013.02.027
Berenson, A. B., & Rahman, M. (2011). Prevalence and correlates of non-medical prescription drug use among young, low-income women receiving public healthcare. Journal of Addictive Diseases, 30(3), 203–215. https://doi.org/10.1080/10550887.2011.581984
Article PubMed PubMed Central Google Scholar
Blanco, C., Alderson, D., Ogburn, E., Grant, B. F., Nunes, E. V., Hatzenbuehler, M. L., & Hasin, D. S. (2007). Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991–1992 and 2001–2002. Drug and Alcohol Dependence, 90(2–3), 252–260.
Boyd, C. J., McCabe, S. E., Cranford, J. A., & Young, A. (2006). Adolescents’ motivations to abuse prescription medications. Pediatrics, 118(6), 2472–2480. https://doi.org/10.1542/peds.2006-1644
Bray, R. M., Pemberton, M. R., Lane, M. E., Hourani, L. L., Mattiko, M. J., & Babeu, L. A. (2010). Substance use and mental health trends among U.S. military active duty personnel: key findings from the 2008 DoD Health Behavior Survey. Military Medicine, 175(6), 390–399. https://doi.org/10.7205/milmed-d-09-00132
Brown, S. A. (2011). Standardized measures for substance use stigma. Drug and Alcohol Dependence, 116(1–3), 137–141. https://doi.org/10.1016/j.drugalcdep.2010.12.005
Compton, W. M., & Volkow, N. D. (2006). Abuse of prescription drugs and the risk of addiction. Drug and Alcohol Dependence, 83(Suppl 1), S4–S7. https://doi.org/10.1016/j.drugalcdep.2005.10.020
Article CAS PubMed Google Scholar
Conway, F. N., Samora, J., Brinkley, K., Jeong, H., Clinton, N., & Claborn, K. R. (2022). Impact of covid-19 among people who use drugs: A qualitative study with harm reduction workers and People Who Use Drugs. Harm Reduction Journal, 19(1). https://doi.org/10.1186/s12954-022-00653-1
Cranford, J. A., McCabe, S. E., & Boyd, C. J. (2013). Adolescents’ nonmedical use and excessive medical use of prescription medications and the identification of substance use subgroups. Addictive Behaviors, 38(11), 2768–2771. https://doi.org/10.1016/j.addbeh.2013.06.015
Cullen, W., Gulati, G., & Kelly, B. D. (2020). Mental health in the COVID-19 pandemic. QJM : Monthly Journal of the Association of Physicians, 113(5), 311–312. https://doi.org/10.1093/qjmed/hcaa110
Article CAS PubMed Google Scholar
Czeisler, M. É., Lane, R. I., Petrosky, E., Wiley, J. F., Christensen, A., Njai, R., Weaver, M. D., Robbins, R., Facer-Childs, E. R., Barger, L. K., Czeisler, C. A., Howard, M. E., & Rajaratnam, S. M. W. (2020). Mental Health, Substance use, and suicidal ideation during the COVID-19 pandemic - United States, June 24–30, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(32), 1049–1057. https://doi.org/10.15585/mmwr.mm6932a1
Dodge, K. A., Skinner, A. T., Godwin, J., Bai, Y., Lansford, J. E., Copeland, W. E., Benjamin Goodman, W., McMahon, R. J., Goulter, N., Bornstein, M. H., Pettit, G. S., & Bates, J. E. (2021). Impact of the COVID-19 pandemic on substance use among adults without children, parents, and adolescents. Addictive Behaviors Reports, 14, 100388. https://doi.org/10.1016/j.abrep.2021.100388
Article PubMed PubMed Central Google Scholar
Drazdowski, T. K., Schulte, M., Wolitzky-Taylor, K. B., Schaper, H., & Chapman, J. E. (2022). Motivations for non-medical prescription drug use related to mental health problems in adults. Substance Use & Misuse, 57(2), 316–327. https://doi.org/10.1080/10826084.2021.2012687
Duden, G. S., Gersdorf, S., & Stengler, K. (2022). Global impact of the COVID-19 pandemic on mental health services: A systematic review. Journal of Psychiatric Research, 154, 354–377. https://doi.org/10.1016/j.jpsychires.2022.08.013
Article PubMed PubMed Central Google Scholar
Dumas, T. M., Ellis, W., & Litt, D. M. (2020). What does adolescent substance use look like during the COVID-19 Pandemic? examining changes in frequency, social contexts, and pandemic-related predictors. The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine, 67(3), 354–361. https://doi.org/10.1016/j.jadohealth.2020.06.018
Fleury, M. J., Grenier, G., Bamvita, J. M., & Caron, J. (2011). Mental health service utilization among patients with severe mental disorders. Community Mental Health Journal, 47(4), 365–377. https://doi.org/10.1007/s10597-010-9320-6
Fleury, M. J., Grenier, G., Bamvita, J. M., Perreault, M., & Caron, J. (2012). Determinants associated with the utilization of primary and specialized mental health services. The Psychiatric Quarterly, 83(1), 41–51. https://doi.org/10.1007/s11126-011-9181-3
Article PubMed PubMed Central Google Scholar
Fleury, M. J., Ngui, A. N., Bamvita, J. M., Grenier, G., & Caron, J. (2014). Predictors of healthcare service utilization for mental health reasons. International Journal of Environmental Research and Public Health, 11(10), 10559–10586. https://doi.org/10.3390/ijerph111010559
Article PubMed PubMed Central Google Scholar
Gage, S. H., Brewer, G., Steen, M., & Lyons, M. (2022). Living with Drug Use and Addiction during the COVID-19 Pandemic. Substance Use & Misuse, 57(10), 1504–1510. https://doi.org/10.1080/10826084.2022.2086695
Gavin, B., Lyne, J., & McNicholas, F. (2020). Mental health and the COVID-19 pandemic. Irish Journal of Psychological Medicine, 37(3), 156–158. https://doi.org/10.1017/ipm.2020.72
Article CAS PubMed PubMed Central Google Scholar
Giuntella, O., Hyde, K., Saccardo, S., & Sadoff, S. (2021). Lifestyle and mental health disruptions during COVID-19. Proceedings of the National Academy of Sciences of the United States of America, 118(9), e2016632118. https://doi.org/10.1073/pnas.2016632118
Article CAS PubMed PubMed Central Google Scholar
Hackman, D. T., Greene, M. S., Fernandes, T. J., Brown, A. M., Wright, E. R., & Chambers, R. A. (2014). Prescription drug monitoring program inquiry in psychiatric assessment: Detection of high rates of opioid prescribing to a dual diagnosis population. The Journal of Clinical Psychiatry, 75(7), 750–756. https://doi.org/10.4088/JCP.14m09020
Article CAS PubMed PubMed Central Google Scholar
Hwang, T. J., Rabheru, K., Peisah, C., Reichman, W., & Ikeda, M. (2020). Loneliness and social isolation during the COVID-19 pandemic. International Psychogeriatrics, 32(10), 1217–1220. https://doi.org/10.1017/S1041610220000988
Knaak, S., Mantler, E., & Szeto, A. (2017). Mental illness-related stigma in healthcare: Barriers to access and care and evidence-based solutions. Healthcare Management Forum, 30(2), 111–116. https://doi.org/10.1177/0840470416679413
Article PubMed PubMed Central Google Scholar
Kulesza, M., Larimer, M. E., & Rao, D. (2013). Substance use related stigma: What we know and the way forward. Journal of Addictive Behaviors, Therapy & Rehabilitation, 2(2), 782. https://doi.org/10.4172/2324-9005.1000106
Kumar, A., & Nayar, K. R. (2021). COVID 19 and its mental health consequences. Journal of Mental Health (abingdon, England), 30(1), 1–2. https://doi.org/10.1080/09638237.2020.1757052
Lankenau, S. E., Schrager, S. M., Silva, K., Kecojevic, A., Bloom, J. J., Wong, C., & Iverson, E. (2012). Misuse of prescription and illicit drugs among high-risk young adults in Los Angeles and New York. Journal of Public Health Research, 1(1), 22–30. https://doi.org/10.4081/jphr.2012.e6
Article PubMed PubMed Central Google Scholar
Lavallée, P. & Beaumont, J.-F. (2015). Why we should put some weight on weights. Survey insights: Methods from the field, weighting: Practical issues and ‘how to’ approach. https://surveyinsights.org/?p=6255
Layman, H. M., Thorisdottir, I. E., Halldorsdottir, T., Sigfusdottir, I. D., Allegrante, J. P., & Kristjansson, A. L. (2022). Substance use among youth during the COVID-19 pandemic: A systematic review. Current Psychiatry Reports, 24(6), 307–324. https://doi.org/10.1007/s11920-022-01338-z
Article PubMed PubMed Central Google Scholar
Lee, Y.-H., Chang, Y.-C., Nabil, A. K., & Barry, A. E. (2023a). Self-reported reasons for opioid and analgesic misuse among participants without cancer in the United States. Journal of Substance Use (online First). https://doi.org/10.1080/14659891.2023.2173096
Lee, Y. H., Hu, J. C., Kimura Park, I., Kim, D., Chiang, T., Shelley, M., & Liu, C. T. (2023b). Examining the association between medical marijuana legalization and criminal behaviors: Evidence from a U.S. representative sample. Substance Use & Misuse, 1–7. https://doi.org/10.1080/10826084.2023.2262022
Lipari, R. N., Park-Lee, E., & Van Horn, S. (2016). America's need for and receipt of substance use treatment in 2015. In The CBHSQ Report. (pp. 1–7). Substance Abuse and Mental Health Services Administration (US).
Matsuzaki, M., Vu, Q. M., Gwadz, M., Delaney, J. A. C., Kuo, I., Trejo, M. E. P., Cunningham, W. E., Cunningham, C. O., & Christopoulos, K. (2018). Perceived access and barriers to care among illicit drug users and hazardous drinkers: Findings from the Seek, Test, Treat, and Retain data harmonization initiative (STTR). BMC Public Health, 18(1), 366. https://doi.org/10.1186/s12889-018-5291-2
Comments (0)